# Top Remote Biotech Companies

Himalayas lists 87 companies for this search, most open remote jobs first.

Source: https://himalayas.app/companies/markets/biotech

## Top Remote Biotech Companies

| Company | Summary | Open remote jobs | Employees |
| --- | --- | --- | --- |
| [Regeneron](https://himalayas.app/companies/regeneron.md) | Regeneron Pharmaceuticals is a leading biotechnology company dedicated to innovating life-changing medicines for serious diseases through proprietary scientific technologies. | 30 | 5000+ |
| [Repligen](https://himalayas.app/companies/repligen.md) | Repligen is a leader in bioprocessing, dedicated to advancing the production of biologic drugs for improved human health. | 18 | 1001-5000 |
| [Adaptive Biotechnologies](https://himalayas.app/companies/adaptive-biotechnologies.md) | Adaptive Biotechnologies is a commercial-stage biotechnology company that harnesses the adaptive immune system's biology to transform disease diagnosis and treatment, offering an immune-sequencing platform for research and clinical diagnostics. | 7 | 501-1000 |
| [BioMarin Pharmaceutical Inc.](https://himalayas.app/companies/biomarin-pharmaceutical-inc.md) | BioMarin Pharmaceutical Inc. is a pioneering biotechnology company focused on developing innovative therapies for genetic disorders, known for its commitment to bold scientific advancements and patient care. | 6 | 1001-5000 |
| [Humacyte](https://himalayas.app/companies/humacyte.md) | Humacyte is a biotechnology company pioneering the development and manufacture of universally implantable, off-the-shelf bioengineered human tissues and organs for treating vascular diseases, trauma, and chronic conditions. The company's FDA-approved product Symvess is used for vascular trauma repair. | 5 | 51-200 |
| [Nacre Capital](https://himalayas.app/companies/nacre-capital.md) | Nacre Capital is a global venture builder dedicated to creating and developing innovative startups that utilize deep technology to impact society positively. | 5 | 11-50 |
| [Seed Health](https://himalayas.app/companies/seed-health.md) | Seed Health is a microbial sciences company pioneering applications of microbes for human and planetary health, developing therapeutics, consumer health innovations, and environmental solutions. | 5 | 51-200 |
| [molecule.xyz](https://himalayas.app/companies/molecule-xyz.md) | Molecule is a technology platform that seeks to revolutionize drug development through a decentralized approach. | 4 | 11-50 |
| [Resilience](https://himalayas.app/companies/resilience.md) | National Resilience, Inc. is an innovative biomanufacturing CDMO focused on improving access to complex medicines through advanced manufacturing solutions. | 4 | 1001-5000 |
| [Lonza](https://himalayas.app/companies/lonza.md) | Lonza Group AG is a Swiss multinational manufacturing company for the pharmaceutical, biotechnology and nutrition sectors, providing product development and custom manufacturing services. | 4 | 5000+ |
| [Northway Biotech](https://himalayas.app/companies/northway-biotech.md) | Northway Biotech is an end-to-end biologics and advanced therapies CDMO with European and US facilities. It supports clients across cell and strain development, process and analytical development, viral clearance, quality and regulatory work, and cGMP commercial manufacturing. | 3 | 201-500 |
| [Endpoints News](https://himalayas.app/companies/endpoints-news.md) | Endpoints News is an independent biotech and pharma news organization providing breaking news, analysis, and exclusive coverage of the science, money, and power driving the biopharma industry, now part of the Financial Times family. | 3 | 51-200 |
| [Jasper Therapeutics](https://himalayas.app/companies/jasper-therapeutics.md) | Jasper Therapeutics is a clinical-stage biotechnology company developing briquilimab, a monoclonal antibody targeting c-Kit, for the treatment of chronic mast cell diseases including chronic spontaneous urticaria, chronic inducible urticaria, and allergic asthma. | 2 | 11-50 |
| [Zealand Pharma](https://himalayas.app/companies/zealand-pharma.md) | Zealand Pharma is a Danish biotechnology company focused on discovering, designing, and developing peptide-based medicines for metabolic diseases, with particular emphasis on obesity and metabolic health treatments. | 2 | 201-500 |
| [BC Platforms](https://himalayas.app/companies/bc-platforms.md) | BC Platforms is a global leader in providing a powerful data and technology platform for personalized medicine and drug development, accelerating the translation of insights into clinical practice. | 2 | 51-200 |
| [Dianthus Therapeutics](https://himalayas.app/companies/dianthus-therapeutics.md) | Dianthus Therapeutics is a clinical-stage biotechnology company focused on complement therapeutics to innovate treatments for autoimmune diseases. | 2 | 51-200 |
| [Cryoport Systems](https://himalayas.app/companies/cryoport-systems.md) | Cryoport Systems is a leading provider of temperature-controlled supply chain solutions, dedicated to supporting the life sciences industry by ensuring the safe transportation and preservation of critical materials. | 2 | 501-1000 |
| [BigHat Biosciences](https://himalayas.app/companies/bighat-biosciences.md) | BigHat Biosciences is pioneering the use of machine learning in antibody therapy development, aiming for improved patient outcomes. | 2 | 51-200 |
| [Shennon Biotechnologies](https://himalayas.app/companies/shennon-biotechnologies.md) | ShennonBio is a precision immunotherapy company developing T-cell engagers for solid tumors using its proprietary TCELERATOR platform that enables ultra-high-throughput single-cell functional screening combined with computational engineering. | 1 | 11-50 |
| [Arbor Biotechnologies](https://himalayas.app/companies/arbor-biotechnologies.md) | Arbor Biotechnologies is a next-generation gene editing company developing potentially curative genomic medicines through programmable DNA editors, with a focus on genetic diseases of the liver and central nervous system. | 1 | 51-200 |

Page 1 of 5. Next page: [page 2](https://himalayas.app/companies/markets/biotech.md?page=2)
